EJP PHARMACEUTICAL ApS: Financial statements 2013
CVR: 87923614
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -394,863 and a net result of DKK 1,207,989 compared with DKK 2,559,450 the year before. Equity amounted to DKK 8,452,867. The solvency ratio was 99.1%.
- Gross Profit
- -394,863 kr.
- Profit/Loss
- 1,207,989 kr.
- Equity
- 8,452,867 kr.
- Total Assets
- 8,529,827 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -395 t. | 1.2 mio. | 8.5 mio. | - |
| 2012 | - | -648 t. | 2.6 mio. | 27.2 mio. | - |
Find more companies like EJP PHARMACEUTICAL ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
EJP PHARMACEUTICAL ApS has published its annual report for 2012. Gross profit came to DKK -647,692, and the net result was DKK 2,559,450.
As of January 17, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of EJP PHARMACEUTICAL ApS.
As of January 17, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of EJP PHARMACEUTICAL ApS.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.
